Company: YEXT
Filing Date: 2025-12-08
Form Type: 10-Q
Source: 0001628280-25-055819
Chunk: 349

Company: Yext, Inc.
Filing Date: 2025-12-08
Form: 10-Q
Item: Part I, Item 8
Chunk 349
---
,525128,036,993123,866,513126,668,394Net income (loss) per share:Net income (loss) per share attributable to common stockholders, basic $0.05 $(0.10)$0.27 $(0.16)Diluted net income (loss) per share:Numerator:Net income (loss) $6,136 $(12,799)$33,657 $(20,673)Fair value adjustment related to contingent consideration(4,300)— (25,900)— Net income (loss), diluted$1,836 $(12,799)$7,757 $(20,673)Denominator:Number of shares used in basic calculation 123,151,525128,036,993123,866,513126,668,394Dilutive effect of employee share-based awards4,169,723 — 4,596,856 — Dilutive effect of incentive pool156,031 — 888,593 — Dilutive effect of earnout arrangement1,411,532 — 949,215 — Weighted-average common shares outstanding, diluted128,888,811128,036,993130,301,177126,668,394Net income (loss) per share attributable to common stockholders, diluted$0.01 $(0.10)$0.06 $(0.16)Since the Company was in a net loss position for the three and nine months ended October 31, 2024, net loss per share attributable to common stockholders was the same on a basic and diluted basis, as the inclusion of all potential common equivalent shares outstanding would have been anti-dilutive. Anti-dilutive common equivalent shares were as follows:Three months ended October 31,Nine months ended October 31,2025202420252024Options to purchase common stock126,750 1,612,009 380,881 1,612,009 Restricted stock and restricted stock units260,884 10,918,443 1,965,779 10,918,443 Shares estimated to be purchased under ESPP— 359,798 — 359,798 Performance-based restricted stock units2,000,000 3,530,000 2,575,000 3,530,000 Total anti-dilutive common equivalent shares2,387,634 16,420,250 4,